The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors

Chinese University of Hong Kong

Overview

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

Study Type

INTERVENTIONAL

Conditions

Diabetes Cardiovascular Risk

Interventions

soy proteinDIETARY_SUPPLEMENT

isoflavonesDIETARY_SUPPLEMENT

milk proteinDIETARY_SUPPLEMENT

Eligibility

Sex: FEMALEMin age: 46 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes Exclusion Criteria: * Women with breast, ovary or other cancers in recent 5-year * Severe renal or liver dysfunction * Women with androgen excess * Smokers * Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.